Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-23-052239

Options or other derivatives

  • Director acquired 191,113 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huang Andong · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +191,113 191,113 D
Loading xslF345X05/doc4.xml…